Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Rising incidence of early-onset colorectal cancer in Australia over two decades: report and review.

Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP, Frank O, Suthers GK, Hewett PJ, Ruszkiewicz A, Hauben E, Adelstein BA, Parry S, Townsend A, Hardingham JE, Price TJ.

J Gastroenterol Hepatol. 2015 Jan;30(1):6-13. doi: 10.1111/jgh.12792.

PMID:
25251195
2.

Patients who take their symptoms less seriously are more likely to have colorectal cancer.

Adelstein BA, Macaskill P, Turner RM, Irwig L.

BMC Gastroenterol. 2012 Sep 22;12:130. doi: 10.1186/1471-230X-12-130.

3.

The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy.

Adelstein BA, Macaskill P, Turner RM, Katelaris PH, Irwig L.

BMC Gastroenterol. 2011 Sep 8;11:97. doi: 10.1186/1471-230X-11-97.

4.

Rapid response systems: a prospective study of response times.

Adelstein BA, Piza MA, Nayyar V, Mudaliar Y, Klineberg PL, Rubin G.

J Crit Care. 2011 Dec;26(6):635.e11-8. doi: 10.1016/j.jcrc.2011.03.013. Epub 2011 Jun 23.

PMID:
21703813
5.

Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review.

Adelstein BA, Macaskill P, Chan SF, Katelaris PH, Irwig L.

BMC Gastroenterol. 2011 May 30;11:65. doi: 10.1186/1471-230X-11-65. Review.

6.

A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer.

Adelstein BA, Dobbins TA, Harris CA, Marschner IC, Ward RL.

Eur J Cancer. 2011 Jun;47(9):1343-54. doi: 10.1016/j.ejca.2011.03.031. Epub 2011 May 5. Review.

PMID:
21550229
7.

Who needs colonoscopy to identify colorectal cancer? Bowel symptoms do not add substantially to age and other medical history.

Adelstein BA, Irwig L, Macaskill P, Turner RM, Chan SF, Katelaris PH.

Aliment Pharmacol Ther. 2010 Jul;32(2):270-81. doi: 10.1111/j.1365-2036.2010.04344.x. Epub 2010 May 3.

PMID:
20456307
8.

A self administered reliable questionnaire to assess lower bowel symptoms.

Adelstein BA, Irwig L, Macaskill P, Katelaris PH, Jones DB, Bokey L.

BMC Gastroenterol. 2008 Mar 1;8:8. doi: 10.1186/1471-230X-8-8.

9.

Availability and development of guidelines in a tertiary teaching hospital.

Guo Y, Adelstein BA, Rubin GL.

J Eval Clin Pract. 2007 Aug;13(4):632-8.

PMID:
17683307
10.

Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia.

Kovoor P, Love A, Hall J, Kruit R, Sadick N, Ho D, Adelstein BA, Ross DL.

Intern Med J. 2005 Sep;35(9):518-25.

PMID:
16105152
11.

High participation rates are not necessary for cost-effective colorectal cancer screening.

Howard K, Salkeld G, Irwig L, Adelstein BA.

J Med Screen. 2005;12(2):96-102.

PMID:
15949121
12.

Is home screening for bowel cancer a good idea?

Adelstein BA, Trevena L, Barratt A, Salkeld G.

Aust N Z J Public Health. 2003;27(3):265-6. No abstract available.

PMID:
14705278
13.

Trial of a trial by media.

Rasmussen HH, Hansen PS, Koyama Y, Adelstein BA, O'Connell AJ, Nelson GI.

Med J Aust. 2001 Dec 3-17;175(11-12):625-8. No abstract available.

PMID:
11837867
14.

Ambulance calls to suspected overdoses: New South Wales patterns July 1997 to June 1999.

Degenhardt L, Hall W, Adelstein BA.

Aust N Z J Public Health. 2001 Oct;25(5):447-50.

PMID:
11688626
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk